Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model

The recent emergence of the SARS-CoV-2 Omicron variant of concern (VOC), which contains a heavily mutated spike protein capable of escaping preexisting immunity, identifies a continued need for interventional measures. Molnupiravir (MK-4482), an orally administered nucleoside analog, has demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenke, Kyle, Okumura, Atsushi, Lewis, Matthew C., Feldmann, Friederike, Meade-White, Kimberly, Bohler, W. Forrest, Griffin, Amanda, Rosenke, Rebecca, Shaia, Carl, Jarvis, Michael A., Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310535/
https://www.ncbi.nlm.nih.gov/pubmed/35579953
http://dx.doi.org/10.1172/jci.insight.160108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310535/
https://www.ncbi.nlm.nih.gov/pubmed/35579953
http://dx.doi.org/10.1172/jci.insight.160108

Ejemplares similares